You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glofitamab

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Large B-cell Lymphoma Trial (Glofitamab, Polatuzumab vedotin, Obinutuzumab)

Not yet recruiting
  • Large B-cell Lymphoma
  • Glofitamab
  • +2 more
  • (no location specified)
Oct 3, 2023

Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Mantle Cell Lymphoma Refractory
  • Glofitamab
  • +3 more
  • (no location specified)
Apr 18, 2023

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Glofitamab
  • +4 more
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

Recruiting
  • Lymphoma
  • Beijing, China
  • +2 more
Oct 12, 2023

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • glofitamab
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 18, 2023

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Glofitamab
  • +5 more
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

DLBCL Trial (maplirpacept (PF-07901801), Glofitamab, Obinutuzumab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • maplirpacept (PF-07901801)
  • +2 more
  • (no location specified)
May 30, 2023

Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)

Not yet recruiting
  • Lymphoma
  • Lymphoma, Large B-Cell, Diffuse
  • Glofitamab
  • +5 more
  • Boston, Massachusetts
  • +1 more
Apr 4, 2023

Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

Not yet recruiting
  • Follicular Lymphoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

Not yet recruiting
  • Mature B-Cell Non-Hodgkin Lymphoma
  • (no location specified)
Sep 6, 2022

Mantle Cell Lymphoma Trial in Duarte (drug, procedure, biological)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

Recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Glofitamab
  • +6 more
  • Pembroke Pines, Florida
  • +3 more
Jan 23, 2023

Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

Not yet recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +2 more
  • Biopsy
  • +8 more
  • Duarte, California
    City of Hope Medical Center
May 15, 2023

Lymphoma Trial in China (Obinutuzumab, Glofitamab, Tocilizumab)

Recruiting
  • Lymphoma
  • Beijing, China
  • +6 more
Aug 4, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Austria, Germany (Glofitamab, Rituximab, Obinutuzumab)

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Glofitamab
  • +3 more
  • Linz, Austria
  • +17 more
Mar 22, 2023

Large B-cell Lymphoma Trial in Philadelphia (mosunetuzumab, glofitamab, obinutuzumab)

Recruiting
  • Large B-cell Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 21, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (RO7443904, Glofitamab, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • New York, New York
  • +7 more
Jan 11, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (RO7227166, Obinutuzumab, Glofitamab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Pasadena, California
  • +14 more
Jan 30, 2023

Lymphoma Trial in Worldwide (Glofitamab, Tocilizumab, Doxorubicin)

Recruiting
  • Lymphoma
  • Glofitamab
  • +6 more
  • Duarte, California
  • +13 more
Aug 18, 2022

B-cell Lymphoma Trial in Randwick, Clayton, Fitzroy (Glofitamab, Gemcitabine, Oxaliplatin)

Completed
  • B-cell Lymphoma
  • Glofitamab
  • +5 more
  • Randwick, New South Wales, Australia
  • +2 more
Nov 23, 2021

Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

Recruiting
  • Non-Hodgkins Lymphoma
  • Glofitamab
  • +5 more
  • Charlotte, North Carolina
  • +21 more
Jan 18, 2023

B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

Active, not recruiting
  • B-Cell Lymphoma
  • Non-Hodgkin Lymphoma
  • Glofitamab
  • +8 more
  • Birmingham, Alabama
  • +23 more
Dec 2, 2022

Diffuse Large B-cell Lymphoma Trial in Worldwide (Obinutuzumab, Glofitamab, Rituxumab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Birmingham, Alabama
  • +77 more
Jul 25, 2022